Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with high mutational heterogeneity and a generally poor clinical outcome. Despite implicated roles of deregulated TP53, IGF-2 and Wnt signaling pathways, a clear genetic association or unique mutational link to the disease is...

Descripción completa

Detalles Bibliográficos
Autores principales: Korah, Reju, Healy, James M, Kunstman, John W, Fonseca, Annabelle L, Ameri, Amir H, Prasad, Manju L, Carling, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750604/
https://www.ncbi.nlm.nih.gov/pubmed/23915220
http://dx.doi.org/10.1186/1476-4598-12-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750604/
https://www.ncbi.nlm.nih.gov/pubmed/23915220
http://dx.doi.org/10.1186/1476-4598-12-87

Ejemplares similares